Corporate Disclosure2026-04-24
Clinical Trial Withdrawn
네오이
네오이뮨텍
950220
Signal Score
50C — Neutral
Score50 / 100
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=7660
Risk-adjusted indicator based on 7660 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Number of clinical trials affected: Not specified
- • Drug name: NTI7 (NIT119)
2 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 투자판단관련주요경영사항(임상시험계획자진취하등) (NTI7(NIT119, 비소세포폐암) 임상 2상 시험 자진취하). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.